1-methylnicotinamide and Its Structural Analog 1,4-dimethylpyridine for the Prevention of Cancer Metastasis

Overview

Journal J Exp Clin Cancer Res

Publisher Biomed Central

Specialty Oncology

Date 2016 Jul 15

PMID 27412454

Citations 16

Authors

Agnieszka Blazejczyk

Marta Switalska

Stefan Chlopicki

Andrzej Marcinek

Jerzy Gebicki

Marcin Nowak

Anna Nasulewicz-Goldeman

Joanna Wietrzyk

Affiliations

Soon will be listed here.

Abstract

Background: 1-methylnicotinamide (1-MNA), an endogenous metabolite of nicotinamide, has recently gained interest due to its anti-inflammatory and anti-thrombotic activities linked to the COX-2/PGI2 pathway. Given the previously reported anti-metastatic activity of prostacyclin (PGI2), we aimed to assess the effects of 1-MNA and its structurally related analog, 1,4-dimethylpyridine (1,4-DMP), in the prevention of cancer metastasis.

Methods: All the studies on the anti-tumor and anti-metastatic activity of 1-MNA and 1,4-DMP were conducted using the model of murine mammary gland cancer (4T1) transplanted either orthotopically or intravenously into female BALB/c mouse. Additionally, the effect of the investigated molecules on cancer cell-induced angiogenesis was estimated using the matrigel plug assay utilizing 4T1 cells as a source of pro-angiogenic factors.

Results: Neither 1-MNA nor 1,4-DMP, when given in a monotherapy of metastatic cancer, influenced the growth of 4T1 primary tumors transplanted orthotopically; however, both compounds tended to inhibit 4T1 metastases formation in lungs of mice that were orthotopically or intravenously inoculated with 4T1 or 4T1-luc2-tdTomato cells, respectively. Additionally, while 1-MNA enhanced tumor vasculature formation and markedly increased PGI2 generation, 1,4-DMP did not have such an effect. The anti-metastatic activity of 1-MNA and 1,4-DMP was further confirmed when both agents were applied with a cytostatic drug in a combined treatment of 4T1 murine mammary gland cancer what resulted in up to 80 % diminution of lung metastases formation.

Conclusions: The results of the studies presented below indicate that 1-MNA and its structural analog 1,4-DMP prevent metastasis and might be beneficially implemented into the treatment of metastatic breast cancer to ensure a comprehensive strategy of metastasis control.

Citing Articles

Unveiling the Nexus: Cellular Metabolomics Unravels the Impact of Estrogen on Nicotinamide Metabolism in Mitigating Rheumatoid Arthritis Pathogenesis.

Malik S, Chakraborty D, Agnihotri P, Kumar V, Biswas S Metabolites. 2024; 14(4).

PMID: 38668342 PMC: 11052502. DOI: 10.3390/metabo14040214.

Defining NAD(P)(H) Catabolism.

Dhuguru J, Dellinger R, Migaud M Nutrients. 2023; 15(13).

PMID: 37447389 PMC: 10346783. DOI: 10.3390/nu15133064.

Anti‑metastatic activity of aromatic aminomethylidenebisphosphonates in a mouse model of 4T1 cell‑derived breast cancer.

Nasulewicz-Goldeman A, Goldeman W, Papiernik D, Nowak M, Mrowczynska E, Wietrzyk J Oncol Rep. 2023; 50(1).

PMID: 37232374 PMC: 10251367. DOI: 10.3892/or.2023.8572.

Remote solid cancers rewire hepatic nitrogen metabolism via host nicotinamide-N-methyltransferase.

Mizuno R, Hojo H, Takahashi M, Kashio S, Enya S, Nakao M Nat Commun. 2022; 13(1):3346.

PMID: 35705545 PMC: 9200709. DOI: 10.1038/s41467-022-30926-z.

Nicotinamide -Methyltransferase in Health and Cancer.

Ramsden D, Waring R, Barlow D, Parsons R Int J Tryptophan Res. 2022; 10:1178646917691739.

PMID: 35185340 PMC: 8851132. DOI: 10.1177/1178646917691739.

References

Chen A, Martin A, Choy B, Fernandez-Penas P, Dalziell R, McKenzie C . A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. N Engl J Med. 2015; 373(17):1618-26. DOI: 10.1056/NEJMoa1506197. View

Schirner M, Schneider M . Cicaprost inhibits metastases of animal tumors. Prostaglandins. 1991; 42(5):451-61. DOI: 10.1016/0090-6980(91)90036-f. View

Daneker G, Lund S, Caughman S, Staley C, Wood W . Anti-metastatic prostacyclins inhibit the adhesion of colon carcinoma to endothelial cells by blocking E-selectin expression. Clin Exp Metastasis. 1996; 14(3):230-8. DOI: 10.1007/BF00053896. View

Kispert S, Marentette J, McHowat J . Enhanced breast cancer cell adherence to the lung endothelium via PAF acetylhydrolase inhibition: a potential mechanism for enhanced metastasis in smokers. Am J Physiol Cell Physiol. 2014; 307(10):C951-6. PMC: 4233261. DOI: 10.1152/ajpcell.00218.2014. View

Larue L, Bellacosa A . Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene. 2005; 24(50):7443-54. DOI: 10.1038/sj.onc.1209091. View

Sartini D, Santarelli A, Rossi V, Goteri G, Rubini C, Ciavarella D . Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma. Mol Med. 2007; 13(7-8):415-21. PMC: 1952675. DOI: 10.2119/2007–00035.Sartini. View

Alston T, Abeles R . Substrate specificity of nicotinamide methyltransferase isolated from porcine liver. Arch Biochem Biophys. 1988; 260(2):601-8. DOI: 10.1016/0003-9861(88)90487-0. View

Maiese K, Chong Z . Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. Trends Pharmacol Sci. 2003; 24(5):228-32. DOI: 10.1016/S0165-6147(03)00078-6. View

Wieczorkowska M, Szajerski P, Michalski R, Adamus J, Marciniak A, Gebicki J . Cytotoxic activity of the selected pyridinium salts against murine leukemia L1210. Pharmacol Rep. 2007; 59(2):216-23. View

10.

Limjeerajarus C, Osathanon T, Manokawinchoke J, Pavasant P . Iloprost up-regulates vascular endothelial growth factor expression in human dental pulp cells in vitro and enhances pulpal blood flow in vivo. J Endod. 2014; 40(7):925-30. DOI: 10.1016/j.joen.2013.10.025. View

11.

Sternak M, Khomich T, Jakubowski A, Szafarz M, Szczepanski W, Bialas M . Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse. Pharmacol Rep. 2010; 62(3):483-93. DOI: 10.1016/s1734-1140(10)70304-2. View

12.

Nojiri T, Hosoda H, Tokudome T, Miura K, Ishikane S, Otani K . Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells. Proc Natl Acad Sci U S A. 2015; 112(13):4086-91. PMC: 4386325. DOI: 10.1073/pnas.1417273112. View

13.

Masclee G, Valkhoff V, Coloma P, de Ridder M, Romio S, Schuemie M . Risk of upper gastrointestinal bleeding from different drug combinations. Gastroenterology. 2014; 147(4):784-792.e9. DOI: 10.1053/j.gastro.2014.06.007. View

14.

Khorana A . Cancer-associated thrombosis: updates and controversies. Hematology Am Soc Hematol Educ Program. 2012; 2012:626-30. DOI: 10.1182/asheducation-2012.1.626. View

15.

Honn K . Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system. Clin Exp Metastasis. 1983; 1(2):103-14. DOI: 10.1007/BF00121490. View

16.

Mateuszuk L, Jasztal A, Maslak E, Gasior-Glogowska M, Baranska M, Sitek B . Antiatherosclerotic Effects of 1-Methylnicotinamide in Apolipoprotein E/Low-Density Lipoprotein Receptor-Deficient Mice: A Comparison with Nicotinic Acid. J Pharmacol Exp Ther. 2015; 356(2):514-24. PMC: 6047228. DOI: 10.1124/jpet.115.228643. View

17.

Majed B, Khalil R . Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn. Pharmacol Rev. 2012; 64(3):540-82. PMC: 3400831. DOI: 10.1124/pr.111.004770. View

18.

Mogielnicki A, Kramkowski K, Pietrzak L, Buczko W . N-methylnicotinamide inhibits arterial thrombosis in hypertensive rats. J Physiol Pharmacol. 2007; 58(3):515-27. View

19.

Sava G, Perissin L, Zorzet S, Piccini P, Giraldi T . Antimetastatic action of the prostacyclin analog iloprost in the mouse. Clin Exp Metastasis. 1989; 7(6):671-8. DOI: 10.1007/BF01753677. View

20.

Aburakawa Y, Kawabe J, Okada M, Yamauchi A, Asanome A, Kabara M . Prostacyclin stimulated integrin-dependent angiogenic effects of endothelial progenitor cells and mediated potent circulation recovery in ischemic hind limb model. Circ J. 2012; 77(4):1053-62. DOI: 10.1253/circj.cj-12-0897. View